相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?
David Marin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy
Steven Richebourg et al.
CANCER GENETICS AND CYTOGENETICS (2008)
On the genesis and prognosis of variant translocations in chronic myeloid leukemia
Madhavi Gorusu et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Fusion tyrosine kinases: a result and cause of genomic instability
E. T. P. Penserga et al.
ONCOGENE (2007)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
Timothy Hughes et al.
BLOOD (2006)
Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome
MMT El-Zimaity et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
分享论文
